Loading...

Glucagon-like peptide 1 and appetite

Glucagon-like peptide 1 (GLP-1) and GLP-1 analogs have received much recent attention due to the success of GLP-1 mimetics in treating type II diabetes mellitus (T2DM), but these compounds may also have the potential to treat obesity. The satiety effect of GLP-1 may involve both meal entero-enteric...

Full description

Saved in:
Bibliographic Details
Main Authors: Dailey, Megan J., Moran, Timothy H.
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594872/
https://ncbi.nlm.nih.gov/pubmed/23332584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tem.2012.11.008
Tags: Add Tag
No Tags, Be the first to tag this record!